Avella Partners with CareSpeak to Launch a New Medication Adherence Program

The program will deliver customized reminders via mobile text messages to patients while offering valuable insights to Avella’s own pharmacists

Avella has just announced the launch of a new medication adherence program developed in partnership with CareSpeak Communications, a leading mobile health services company. Designed to be simple, secure and convenient for users, the program sends text alerts when it is time for a patient to take or refill their medication.

These alerts can be customized to deliver results for patients with even the most complex medication regimens. In fact, a CareSpeak pilot study demonstrated a 29 percent increase in adherence rates for patients who had low compliance with their drug regimen prior to enrolling in the program. Text messaging-based adherence programs have delivered impressive results in other settings as well. A variety of peer-reviewed studies have shown that these programs double the rates of medication adherence for middle-aged people with chronic diseases.

Medication non-adherence presents a serious challenge not just for pharmacies but for healthcare organizations across the continuum of care. Adherence rates are tied to both cost and quality of care. Studies show that half of all patients don’t take their medications as prescribed, and this poor adherence drives approximately $105 billion in avoidable healthcare costs.

While easy to use for patients, this new CareSpeak program also provides actionable insights for Avella’s pharmacists, who receive updates and adherence reporting from the system in a secure dashboard. Armed with this information, pharmacists can triage and target their high-touch outreach for patients. These insights can also be shared with the patient’s care team as authorized—informing providers and/or care managers about adherence levels that can impact the quality of care.

"Given the proven results delivered by this program, we are very excited to offer it to our patients," said Rebecca M. Shanahan, CEO of Avella. "We will also be using the insights it delivers to optimize our overall adherence and patient engagement efforts." To learn more, please visit: www.avella.com/carespeak

About Avella Specialty Pharmacy

Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine’s 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. In addition, the Arizona Corporate Excellence Awards named Avella Specialty Pharmacy as the second fastest-growing private company based in the state in 2015. For more information, please visit www.avella.com.

About CareSpeak Communications, Inc.

CareSpeak intelligent health messages provide patients with an effortless way to mange their health, powered by an advanced digital health platform. The HIPAA compliant platform provides patient engagement, medical therapy adherence, and care coordination solutions to global health insurers, pharmaceutical companies, pharmacies and specialty pharmacies as well as clinicians at some of the leading medical centers. CareSpeak Communications is a privately held company, headquartered in Somerset, New Jersey.